‘æ15‰ñŽŸ¢‘ã‚ð’S‚¤ŽáŽèˆã—Öò‰ÈŠwƒVƒ“ƒ|ƒWƒEƒ€—DG”­•\Ü  
(ŒÜ\‰¹‡)  
yŒû“ª”­•\‚Ì•”z

–kŠC“¹‘åŠw‘åŠw‰@–òŠwŒ¤‹†‰@@@ŒE“c@•¶‰À@“a
‰‰@‘èFDevelopment of Mitochondrial-targeted Nanocarrier for Photodynamic Therapy Using the Microfluidic Device
Š@‘®F1Faculty of Pharmaceutical Sciences, Hokkaido University, 2School of Pharmacy, Institut Teknologi Bandung, 3Research Institute for Electronic Science, Hokkaido University, 4Faculty of Engineering, Hokkaido University
”­•\ŽÒFFumika Kubota1, Yuuma Yamada1, Satrialdi2, Yuuta Takano3, Masatoshi Maeki4, Manabu Tokeshi4, Hideyoshi Harashima1

‹à‘ò‘åŠwˆã–ò•ÛŒ’Šwˆæ–òŠw—Þ@@ŠÖ@—T‘¾@“a
‰‰@‘èFImpact of serotonin-associated gut microbiota dynamics on drug-induced gastrointestinal toxicity
Š@‘®FFaculty of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University
”­•\ŽÒFYuta Seki, Yoshiyuki Shirasaka, Yuta Funai, Suguru Asaji, Ikumi Tamai

“Œ‹ž‘åŠw‘åŠw‰@–òŠwŒnŒ¤‹†‰È@@‹´–{@–FŽ÷@“a@
‰‰@‘èFBasic Characterization of Drug-induced Gastrointestinal Toxicity Using Cultured Intestinal Stem Cells Originated from Region-specific Crypts in Monkeys, Dogs and Humans
Š@‘®F1Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 2Laboratory of Pharmaceutics, Kitasato University School of Pharmacy, 3Shin Nippon Biomedical Laboratories, Ltd., 4Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Faculty of Medicine, University of Tsukuba
”­•\ŽÒFYoshiki Hashimoto1, Kazuya Maeda1,2, Kazuyoshi Michiba1, Akiko Moriyama3, Ko Kurimori4, Tsuyoshi Enomoto4, Osamu Shimomura4, Tatsuya Oda4, Hiroyuki Kusuhara1

‹ž“s‘åŠw‘åŠw‰@–òŠwŒ¤‹†‰È@@•½“c@„@“a@
‰‰@‘èFSite-directed connection of functional protein on cell membrane via click reaction
Š@‘®FGraduate School and Faculty of Pharmaceutical Sciences, Kyoto University
”­•\ŽÒFTsuyoshi Hirata, Tomoka Kunii, Misaki Yokota, Yuriko Higuchi, Fumiyoshi Yamashita

‹ãB‘åŠw‘åŠw‰@–òŠwŒ¤‹†‰@@@ŽR“à@’q‹Å@
‰‰@‘èFDisruption of circadian metabolic regulation of cysteine contributes to the rapid growth and malignancy of murine hepatic cancer cells
Š@‘®F1Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyushu University, 2Department of Glocal Healthcare Science, Faculty of Pharmaceutical Sciences, Kyushu University, 3Department of Clinical Pharmacokinetics, Faculty of Pharmaceutical Sciences, Kyushu University
”­•\ŽÒFTomoaki Yamauchi1, Yumi Okano1, Sai Yasukochi1, Yuya Yoshida1, Akito Tsuruta1,2, Naoya Matsunaga3, Satoru Koyanagi1,2, Shigehiro Ohdo1

 
 yƒ|ƒXƒ^[”­•\‚Ì•”z

“¿“‡‘åŠw‘åŠw‰@ˆãŽ•–òŠw‹³ˆç•”@@‰^“V@Šgl@“a
‰‰@‘èFExploration of prophylactic drugs against doxorubicin-induced cardiomyopathy using largescale medical databases
Š@‘®F1Tokushima University Graduate School of Biomedical Sciences, Department of Clinical Pharmacology and Therapeutics, 2Okayama University Hospital, Department of Pharmacy, 3Tokushima University Hospital, Department of Pharmacy, 4Tokushima University Hospital, Clinical Trial Center for Developmental Therapeutics
”­•\ŽÒFHiroto Unten1, Hirohumi Hamano4, Takahiro Niimura3, Nanami Tomotika1, Shiori Nishiuti1,3, Mituhiro Gouda1,3, Kenta Yagi4, Fuka Aizawa1,2, Yoshito Zamami2, Keisuke Ishizawa1,3

“Œ‹ž‘åŠw‘åŠw‰@–òŠwŒnŒ¤‹†‰È@@“¹ê@ˆêË@“a
‰‰@‘èFCharacterization of human jejunal spheroid-derived intestinal epithelial cells for the evaluation of human intestinal absorption properties of substrates of drug-metabolizing enzymes and transporters
Š@‘®F1Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 2Laboratory of Pharmaceutics, Kitasato University School of Pharmacy, 3Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Faculty of Medicine, University of Tsukuba
”­•\ŽÒFKazuyoshi Michiba1, Kazuya Maeda1,2, Ko Kurimori3, Tsuyoshi Enomoto3, Osamu Shimomura3, Tatsuya Oda3, Hiroyuki Kusuhara1